Hyperfine (NASDAQ:HYPR) Cut to Sell at Wall Street Zen

Wall Street Zen downgraded shares of Hyperfine (NASDAQ:HYPR) from a hold rating to a sell rating in a research note published on Saturday,Wall Street Zen reports.

Several other research firms have also recently issued reports on HYPR. B. Riley Financial reiterated a “buy” rating and issued a $1.60 price objective (down from $2.00) on shares of Hyperfine in a research report on Monday, August 10th. Weiss Ratings reissued a “sell (d-)” rating on shares of Hyperfine in a report on Thursday, October 15th. Loop Capital set a $2.00 target price on shares of Hyperfine in a research report on Tuesday, October 27th. BTIG Research restated a “buy” rating and set a $2.00 target price on shares of Hyperfine in a research report on Tuesday, September 22nd. Finally, Lucid Cap Mkts began coverage on shares of Hyperfine in a research note on Tuesday, October 27th. They set a “strong-buy” rating on the stock. One research analyst has rated the stock with a Strong Buy rating, three have issued a Buy rating, one has issued a Hold rating and one has assigned a Sell rating to the company’s stock. According to data from MarketBeat.com, the stock has an average rating of “Moderate Buy” and an average target price of $2.02.

Hyperfine Stock Performance

NASDAQ HYPR opened at $0.72 on Friday. The company has a current ratio of 6.15, a quick ratio of 5.45 and a debt-to-equity ratio of 0.36. The business’s 50 day moving average is $0.81 and its two-hundred day moving average is $1.12. Hyperfine has a 12-month low of $0.70 and a 12-month high of $1.94. The stock has a market capitalization of $76.36 million, a price-to-earnings ratio of -1.89 and a beta of 1.45.

Hyperfine (NASDAQ:HYPR) last issued its earnings results on Thursday, August 6th. The company reported ($0.09) earnings per share (EPS) for the quarter, hitting analysts’ consensus estimates of ($0.09). The business had revenue of $3.90 million during the quarter, compared to the consensus estimate of $4.13 million. Hyperfine had a negative return on equity of 97.88% and a negative net margin of 210.75%. Research analysts expect that Hyperfine will post -0.34 EPS for the current year.

Institutional Investors Weigh In On Hyperfine

A number of hedge funds and other institutional investors have recently modified their holdings of HYPR. Walleye Capital LLC grew its holdings in shares of Hyperfine by 3.4% in the 1st quarter. Walleye Capital LLC now owns 223,988 shares of the company’s stock worth $242,000 after acquiring an additional 7,330 shares during the period. PFS Partners LLC increased its stake in Hyperfine by 150.0% in the 3rd quarter. PFS Partners LLC now owns 50,000 shares of the company’s stock valued at $40,000 after purchasing an additional 30,000 shares in the last quarter. Bank of New York Mellon Corp purchased a new position in Hyperfine in the 2nd quarter valued at approximately $419,000. Finally, Renaissance Technologies LLC increased its stake in Hyperfine by 100.2% in the 1st quarter. Renaissance Technologies LLC now owns 730,233 shares of the company’s stock valued at $789,000 after purchasing an additional 365,490 shares in the last quarter. 15.03% of the stock is currently owned by institutional investors and hedge funds.

Hyperfine Company Profile

Hyperfine, Inc (NASDAQ: HYPR) is a medical technology company focused on making magnetic resonance imaging more accessible and convenient. The company develops portable, low-field MRI technology designed to bring brain imaging directly to patients in locations such as intensive care units, emergency departments, operating rooms and other point-of-care settings.

Hyperfine’s primary product is the Swoop Portable MR Imaging System, a compact MRI platform that can be moved to a patient’s bedside.